Live Breaking News & Updates on Amyloidosis Centre|Page 5

Stay updated with breaking news from Amyloidosis centre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Birtamimab Plus Standard-Of-Care in Light Chain Amyloidosis: The Phase 3 Randomized, Placebo-Controlled VITAL Trial

SPONSORED CONTENT: Morie Gertz, MD, reviews data on the use of birtamimab plus standard-of-care anti-plasma cell chemotherapy in patients with light-chain amyloidosis, which was investigated in the phase 3 randomized, placebo-controlled VITAL trial. ....

Birtamimab Plus Standard Of Care , Light Chain Amyloidosis , Standard Of Care Therapies Light Chain Amyloidosis , Standard Of Care Treatment Light Chain Amyloidosis , Anti Plasma Cell Chemotherapy , Chemotherapy Amyloidosis , Birtamimab Amyloidosis ,

FDA Denies Approval for Patisiran in ATTR Cardiomyopathy

In a complete response letter, the FDA said the clinical meaningfulness of patisiran s effects in cardiomyopathy of ATTR amyloidosis are not established, despite good reviews from an advisory panel. ....

Yvonne Greenstreet , Alnylam Pharmaceuticals , Drug Administration , Renal Drugs Advisory Committee , Us Food And Drug Administration , Nited States Food And Drug Administration ,

How Stress Strains Your Digestive Health?

Stress affects the brain-gut connection, impacting the gut s ability to contract and relax, leading to a variety of digestive issues. ....

Keep Calm , Digestive Problems , Gut Health , Brain Gut Connection ,